Authors: Pratibha Anand 1, Vincent P Stahel 2 Abstract The novel coronavirus disease 2019 (COVID-19) has infected more than 100 million people globally within the first year of the pandemic. With a death…[...]
Read More
Authors: Musha Chen, Yue Yuan, Yiguo Zhou, Zhaomin Deng, Jin Zhao, Fengling Feng, Huachun Zou & Caijun Sun Background Various modalities of vaccines against coronavirus disease 2019 (COVID-19), based on different platforms and immunization procedures, have been successively…[...]
Read More
Authors: Anne M. Hause, PhD1; Julianne Gee, MPH1; James Baggs, PhD1; Winston E. Abara, MD1; Paige Marquez, MSPH1; Deborah Thompson, MD2; John R. Su, MD, PhD1; Charles Licata, PhD1; Hannah…[...]
Read More
Authors: Project director: Nikhil K. Mull, MD (CEP), Lead analyst: Matthew D. Mitchell, PhD (CEP), Clinical review: Patrick J. Brennan, MD. (CMO) EVIDENCE SUMMARY: 1. There are no specific guidelines…[...]
Read More
https://www.openvaers.com/covid-data Important Things To Know About VAERS VAERS is an early warning system used to monitor adverse events that happen after vaccination. VAERS is the frontline system of a comprehensive vaccine safety monitoring…[...]
Read More
Author: Dr. Charles Hoffe in a Coronavirus, that spike protein becomes part of the viral capsule. In other words, the cell wall around the virus, called the viral capsule. But…[...]
Read More
Authors: Johns Hopkins Dr. Marty Makary The news about the U.S. Covid pandemic is even better than you’ve heard. Some 80% to 85% of American adults are immune to the…[...]
Read More
Authors: Dr. Mercola Interviews the Experts Any medical treatment must be evaluated along a cost-benefit analysis. No treatment is risk free. It is in this respect that transparent availability of…[...]
Read More
Authors: Gerard Clarke The Former Vice President of Pfizer, Dr. Michael Yeadon, has said that there is “demonstrably false” propaganda coming from governments in response to COVID-19, including the “lie”…[...]
Read More
Authors: Dr. Joseph Mercola Canadian immunologist and vaccine researcher Byram Bridle, Ph.D., has gained access to Pfizer’s biodistribution study from the Japanese regulatory agency. The research, previously unseen, demonstrates a…[...]
Read More